Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03718221 · ClinicalTrials.gov registry record · NA

Geographically Clustered Mailing of Fecal Immunochemical Test (FIT) Kits

A NA study, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
8,653
Enrollment target

NCT03718221 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 8,653 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03718221, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
8,653 participants
Enrollment target

Study Summary

This is a pragmatic, randomized, controlled trial of a geographically randomized intervention in which all eligible patients will receive a mailed fecal immunochemical test (FIT) kit (the GeoMail study). In this study, all ZIP Codes in Dallas County will be randomized to either treatment or usual care. Patients in treated neighborhoods will receive kits at the same time; patients in usual care neighborhoods will receive FIT kits randomly throughout the year. All eligible patients will receive a FIT kit each year. The trial will be conducted in a racially and socioeconomically diverse cohort of patients served by an integrated safety net delivery system. This study represents a pragmatic adaptation to the "FIT first" population health screening strategy in which all eligible patients are mailed FIT kits. All patients will also have access to whatever colorectal cancer (CRC) screening is recommended through usual visit-based care.

Interventions

  • OTHER Usual Care FIT Screening Strategy
  • OTHER GeoMail FIT Screening Strategy

Trial Details

FieldValue
Enrollment Target 8,653 participants
Start Date 2018-08-30
Est. Completion 2021-08-30
Phase NA

What the Registry Record Tells You About NCT03718221

The ClinicalTrials.gov registry entry for NCT03718221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8,653 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual Care FIT Screening Strategy is the first listed.

NCT03718221 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03718221 about?

NCT03718221 is a clinical study titled "Geographically Clustered Mailing of Fecal Immunochemical Test (FIT) Kits". This is a pragmatic, randomized, controlled trial of a geographically randomized intervention in which all eligible patients will receive a mailed fecal immunochemical test (FIT) kit (the GeoMail study). In this study, all ZIP Codes in Dallas County will be randomized to either treatment or usual ca...

What is the current status of trial NCT03718221?

This trial is currently completed. It is a NA study. The enrollment target is 8,653 participants. The study started on 2018-08-30. Estimated completion is 2021-08-30.

What interventions are being tested in trial NCT03718221?

The interventions under investigation include: Usual Care FIT Screening Strategy (OTHER), GeoMail FIT Screening Strategy (OTHER).

Who is sponsoring clinical trial NCT03718221?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.